Reports From the Field

Improving Nephropathy Screening in Appalachian Patients With Diabetes Using Practice-Wide Outreach


 

References

Conclusion

Although this evaluation does not provide insight into why patients were not treated or screened, it demonstrates processes to improve compliance in patients with diabetic nephropathy. Rural health care facilities require an ongoing program of change and evaluation, with the aim to improve the provision of services, increase screening, and encourage team member involvement in health promotion. This study demonstrates that combining team-based interventions with quality control monitoring can significantly improve compliance with recommended nephropathy screening and treatment in rural patients with diabetes at a family medicine clinic.

Corresponding author: Amie M. Ashcraft, West Virginia University, Department of Family Medicine, 1 Medical Center Drive, Box 9152, Morgantown, WV 26506; amashcraft@hsc.wvu.edu.

Financial disclosures: None.

Acknowledgment: The authors thank the faculty, residents, nurses, and clinic staff for their hard work and dedication to this effort: Umama Sadia, Michelle Prestoza, Richard Dattola, Greg Doyle, Dana King, Mike Maroon, Kendra Under, Judy Siebert, Christine Snyder, Rachel Burge, Meagan Gribble, Lisa Metts, Kelsey Samek, Sarah Deavers, Amber Kitzmiller, Angela Lamp, Tina Waldeck, and Andrea Sukeruksa.

Pages

Recommended Reading

SGLT2 inhibitors for diabetes safe, effective in older adults
Journal of Clinical Outcomes Management
Score predicts bariatric surgery’s benefits for obesity, type 2 diabetes
Journal of Clinical Outcomes Management
Carbohydrate restriction a viable choice for reversal of type 2 diabetes, expert says
Journal of Clinical Outcomes Management
Gout rates reduced with SGLT2 inhibitors
Journal of Clinical Outcomes Management
FDA warns of possible cancer risk with lorcaserin
Journal of Clinical Outcomes Management
Bariatric surgery is most effective early in the diabetes trajectory
Journal of Clinical Outcomes Management
Sarcopenia associated with increased cardiometabolic risk
Journal of Clinical Outcomes Management
FDA approves CV disease benefit for once-weekly semaglutide
Journal of Clinical Outcomes Management
Gestational diabetes: Treatment controversy rages on
Journal of Clinical Outcomes Management
Noninjectable modes of insulin delivery coming of age
Journal of Clinical Outcomes Management